Screener

Eligibility screening

Testing the Addition of Venetoclax and/or Blinatumomab to Chemotherapy for Infants with Newly Diagnosed Leukemia

Sponsored by National Cancer Institute (NCI)Study detailsClinicalTrials.gov

106 US sites in AK, AL, AR, AZ +36

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.